Medtech Acquisition Corp.
13F holders, Q4 2025 (December 31)3holders −1
1new positions
2sold out
$6.98avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Medtech Acquisition Corp. in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 2 sold out. The largest holders were Captrust Financial Advisors ($152K), JDM Financial Group LLC ($4K) and Rothschild Investment LLC ($7).
- Company
- Medtech Acquisition Corp.
- Filed as
- TRISALUS LIFE SCIENCES INC COM (Q4 2025)
- CUSIP
- 58507N105
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7 |
| Exits | 2 | $479 |
All 13F filers, Q3 2025 → Q4 2025: 8 shares bought and 103 shares sold, net −95 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Captrust Financial Advisors | 0.00% | Add +0.0% | 21,834 | $152K |
| JDM Financial Group LLC | 0.00% | No change | 530 | $4K |
| Rothschild Investment LLC | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is MEDTECH ACQUISITION CORP's weight in each manager's 13F, not the share of Medtech Acquisition Corp. the manager owns.